Who invested in Cohera Medical?
Cohera Medical's investors include Kern Whelan Capital, KKR & Co. (Kohlberg Kravis Roberts & Co.) and Bradford Capital Holdings.
United States · Venture startup
9 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$144Mraised across 9 rounds since 2008, from 9 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $30M sold, first sale Oct 2015
No investor was named in the report.
From a historical funding recordSEC filing: $9.2M sold, first sale Jan 2014
No investor was named in the report.
From a historical funding recordSEC filing: $7.3M sold, first sale Jan 2013
No investor was named in the report.
Reported by sec.govSEC filing: $7.3M sold, first sale Jan 2013
No investor was named in the report.
Reported by sec.govSEC filing: $8.4M sold, first sale Jun 2012
No investor was named in the report.
Reported by coheramedical.comSEC filing: $8.4M sold, first sale Jun 2012
Reported by finsmes.comSEC filing: $6.3M sold, first sale Nov 2011
No investor was named in the report.
From a historical funding recordSEC filing: $12M sold, first sale May 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Cohera Medical's investors include Kern Whelan Capital, KKR & Co. (Kohlberg Kravis Roberts & Co.) and Bradford Capital Holdings.
Cohera Medical has raised $144M across 9 rounds since 2008.
Cohera Medical's most recent round was a Venture of $50M in Oct 2015.
Its most recent round, $50M in Oct 2015, is also its largest on record.
Cohera Medical's first round on record, in Oct 2008, was backed by Kern Whelan Capital and Bradford Capital Holdings.
Cohera Medical's latest named round is a Venture, in Oct 2015.
Cohera Medical is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.